BN

Brookfield
D

BN

Arincen42/100B

Brookfield financials

Yes. Brookfield earned 1.42B USD of net income over the last twelve months, 1.8% of its revenue. It made a profit in 29 of its 30 fiscal years since 1996. Its last loss was in fiscal year 2020.

Revenue (TTM)
77.77B USD
Net income (TTM)
1.42B USD
Cash and short-term investments
14.89B USD
Total debt
264.98B USD
Shareholders' equity
46.57B USD

Cash, debt and equity as of 30 Jun 2026.

Brookfield earnings

Next earnings · Q3 FY2026
EPS estimate
0.68 USD
Revenue estimate
1.78B USD
Last quarter · Q2 FY2026
EPS0.60Missed -2.9%Revenue1.62BMissed -2.2%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q3 FY20260.68——+8.25%1.78B——-90.58%
Q2 FY20260.620.60-2.92%-31.93%1.66B1.62B-2.23%+9.30%
Q1 FY20260.600.58-3.32%-10.46%1.62B1.63B+0.75%+13.22%
Q4 FY20250.610.67+9.84%0.00%1.63B1.71B+4.96%+33.29%
Q3 FY20250.590.63+6.24%+12.50%11.77B18.92B+60.72%+1,337.25%
Q2 FY20250.590.88+48.40%-2.22%1.44B1.49B+2.85%+23.30%
Q1 FY20250.590.65+10.17%+27.45%1.36B1.44B+5.75%+10.26%

Brookfield growth and profitability

Full income statement
Revenue (TTM)
77.77B USD
Net income (TTM)
1.42B USD
Gross margin
28.76%
Operating margin
28.56%
Net margin
1.82%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY202576.13B-11.49%1.31B+103.90%38.80%28.60%1.72%32.77B+12.29%
FY202486.01B-10.34%641.00M-43.27%21.01%20.92%0.75%29.19B-4.91%
FY202395.92B+3.40%1.13B-45.04%15.13%15.06%1.18%30.69B+22.54%
FY202292.77B+22.50%2.06B-48.16%15.37%15.24%2.22%25.05B-12.88%
FY202175.73B+20.68%3.97B—15.49%15.34%5.24%28.75B+97.64%

How Brookfield makes its money

Revenue76.13B 100.0%
Cost of revenue46.59B 61.2%
Gross profit29.53B 38.8%
Selling and administration78.00M 0.1%
Other operating expenses7.68B 10.1%
Operating income21.78B 28.6%
Tax1.14B 1.5%
Other expense19.33B 25.4%
Net income1.31B 1.7%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

Brookfield revenue breakdown

By region

FY2025
United States: 40.2%Canada: 11.5%Other Europe: 10.3%Brazil: 8.0%Australia: 7.8%India: 6.2%Other Countries: 4.6%Other Asia: 4.0%Colombia: 3.9%Germany: 3.4%40.2%United States11.5%Canada10.3%Other Europe8.0%Brazil7.8%Australia6.2%India4.6%Other Countries4.0%Other Asia3.9%Colombia3.4%Germany
RegionRevenueShare of revenueChange on the year
United States27.36B40.2%+4.7%
Canada7.81B11.5%-11.9%
Other Europe7.02B10.3%-20.3%
Brazil5.48B8.0%+4.8%
Australia5.31B7.8%-20.5%
India4.25B6.2%+8.1%
Other Countries3.14B4.6%+25.5%
Other Asia2.74B4.0%-11.8%
Colombia2.68B3.9%-2.7%
Germany2.32B3.4%+0.5%

Operating and free cash flow

Full cash flow statement
Operating cash flow Free cash flow
Fiscal yearOperating cash flowFree cash flow
FY20250.000.00
FY20247.21B-3.43B
FY20236.59B-1.63B
FY20228.40B1.45B
FY20217.80B984.26M
FY20208.78B4.56B
FY20196.48B3.35B
FY20184.90B3.03B
FY20174.15B2.40B
FY20163.05B1.59B

Brookfield financial health

Full balance sheet
Cash and short-term investments
14.89B USD
Total debt
264.98B USD
Net cash
-250.10B USD
Free cash flow (TTM)
-8.30B USD
Current ratio
1.14
Debt to equity
5.69
Piotroski score
5 / 9
Altman Z-score
0.52

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY202516.24B312.61B0.00
FY202420.18B234.79B-3.43B
FY202316.89B233.71B-1.63B
FY202221.96B214.07B1.45B
FY202119.66B175.93B984.26M

Assets, liabilities and equity

Total assets Total liabilities Shareholders' equity
Fiscal yearTotal assetsTotal liabilitiesShareholders' equity
FY2025518.97B352.78B47.80B
FY2024490.42B325.04B45.98B
FY2023490.10B321.85B45.78B
FY2022441.28B299.39B43.75B
FY2021391.00B256.26B46.36B
FY2020343.70B221.05B35.84B
FY2019323.97B207.12B35.01B
FY2018256.28B159.13B29.82B
FY2017192.72B112.85B28.24B
FY2016159.83B90.14B26.45B

Brookfield valuation

Price to earnings ratio (TTM)
75.76
Forward P/E (FY2026)
15.45
Price to sales (TTM)
1.22
Price to book
2.04
EV / EBITDA (TTM)
10.30

Capital structure

Market capitalization
94.94B USD
+
Total debt
264.98B USD
−
Cash and short-term investments
14.89B USD
=
Enterprise value
345.04B USD

Valuation over time

Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
Now (TTM)75.76—1.222.0410.30
FY202591.78—1.432.2712.36
FY2024185.32—1.011.8910.50
FY202364.72—0.651.379.29
FY202225.78—0.531.139.94
FY202119.76—0.991.628.29

Brookfield against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: KKR & Co., Brookfield Asset Management, Apollo Global Management, Blackstone, BlackRock, and State Street, the US Asset Management companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Above its median75.8
    8.9247.2
  • Gross marginHighest in 5 years38.8%
    15.1%38.8%
    Against its peers: 6 of 7Peers' median 65.8%
  • Operating marginHighest in 5 years28.6%
    15.1%28.6%
    Against its peers: 4 of 7Peers' median 27.4%
  • Net marginAt its median1.7%
    0.7%5.2%
    Against its peers: 7 of 7Peers' median 17.4%
  • Return on equityAt its median2.7%
    1.4%8.6%
    Against its peers: 7 of 7Peers' median 12.8%
  • Free cash flow marginAt its median0.0%
    -4.0%1.6%
    Against its peers: 7 of 7Peers' median 16.8%
  • Revenue growthLowest in 5 years-11.5%
    -11.5%22.5%
    Against its peers: 7 of 7Peers' median 17.2%
  • EPS growthHighest in 5 years141.9%
    -50.2%141.9%
    Against its peers: 1 of 7Peers' median -4.4%
  • Debt to EBITDAHighest in 5 years9.54×
    6.12×9.54×
    Against its peers: 7 of 7Peers' median 1.85×
  • Current ratioHighest in 5 years1.14
    0.511.14
    Against its peers: 4 of 7Peers' median 1.17

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

Brookfield dividends

Annual dividend
0.28 USD
Dividend yield (indicated)
0.66%
Payout ratio
48.09%
Years of dividend growth
12
Frequency
Quarterly
Last payment
0.07 USD
Last ex-dividend date
14 Sept 2026
Last payment date
29 Sept 2026

Dividends per share

Year2025202420232022202120202019201820172016
Dividends per share0.240.210.190.300.280.260.230.210.240.18

Brookfield ownership

Institutions
59.89%
Institutional holders
968 (+27)
Free float
59.81%

Who owns the shares

Institutions 59.9% Others 40.1%
As of 30 Jun 2026

Shares free to trade

Free float 1.34B shares ·59.8% Closely held 897.20M shares ·40.2%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q3 2023000.00281.44K
Q4 2022000.0065.00K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY20252.37B2.37B-0.42%
FY20242.27B2.38B-0.23%
FY20232.34B2.38B-1.24%
FY20222.35B2.41B+1.34%
FY20212.30B2.38B+3.00%

Common questions about Brookfield's financials

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.